Navigator Medicines, Inc.

New Filing
CIK: 0002035715·Biotechnology·DELAWARE·Filed: Sep 25, 2026
Total Offering

$40,000,000

Amount Sold

$10,000,000

Investors

3

First Sale

Sep 18, 2026

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2024
Non-Accredited Investors
No

Related Persons

NameRole
TAUSIF BUTT
STEPHEN BASIL THOMAS
SCOTT FORREST
WOUTER JOUSTRA
KHUREM FAROOQ
MATHIAS VINTHER
KRISTIE GREBE

Company

Navigator Medicines, Inc.

1825 S GRANT ST.

SAN MATEO, CA, 94402

650-240-8794

SEC Filing

0002035715-26-000005

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free